World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 11

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5805)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

217

WORD

HTML

2739

Figures (1-1)

576

Tables (1-4)

537

Sum=4088

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

315

Download

1162

Sum=1477

Nov 27, 2023 (publication date) through Apr 17, 2026

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Ward JA, Yerke J, Lumpkin M, Kapoor A, Lindenmeyer CC, Bass S. Evaluation of a protocol for rifaximin discontinuation in critically ill patients with liver disease receiving broad-spectrum antibiotic therapy. World J Hepatol 2023; 15(11): 1226-1236 [PMID: 38075005 DOI: 10.4254/wjh.v15.i11.1226]
URL:	https://www.wjgnet.com/1948-5182/full/v15/i11/1226.htm

Number	Citing Articles
1	Wen Wang, Ying Wen. The role of systemic inflammation in hepatic encephalopathy: advances in inflammatory mechanisms, prevention and treatment research. Annals of Medicine 2026; 58(1) doi: 10.1080/07853890.2026.2650232
2	Lorenzo Ridola, Alessandro Mari. Rifaximin discontinuation during broad-spectrum antibiotic treatment in critically ill patients with hepatic encephalopathy. World Journal of Hepatology 2024; 16(11): 1356-1360 doi: 10.4254/wjh.v16.i11.1356 Abstract(547) \| Core Tip(549) \| Full Article(HTML)(1646) \| Full Article with Cover (PDF)-2476K(137) \| Audio-16465K(11) \| Peer-Review Report-394K(84) \| Answering Reviewers-69K(112) \| Full Article (PDF)-369K(165) \| Full Article (XML)-59K(121) \| Times Cited (1) \| Total Visits (4883) \| Open
3	Jasmohan S. Bajaj, Sofia S. Jakab, Arun B. Jesudian, Robert S. Rahimi, Andres Duarte-Rojo, Po-Hung Chen, Robert J. Wong, Elliot B. Tapper, Puneeta Tandon. ACG Clinical Guideline: Hepatic Encephalopathy. American Journal of Gastroenterology 2026; 121(3): 588 doi: 10.14309/ajg.0000000000003899
4	Piero Amodio, Chien-Hao Huang. Can rifaximin for hepatic encephalopathy be discontinued during broad-spectrum antibiotic treatment?. World Journal of Hepatology 2024; 16(2): 115-119 doi: 10.4254/wjh.v16.i2.115 Abstract(774) \| Core Tip(641) \| Full Article(HTML)(2975) \| Full Article with Cover (PDF)-875K(202) \| Full Article (Word)-129K(14) \| Audio-162K(29) \| Peer-Review Report-172K(118) \| Answering Reviewers-129K(119) \| Full Article (PDF)-363K(191) \| Full Article (XML)-64K(123) \| Times Cited (3) \| Total Visits (8780) \| Open
5	Zhaohui Bai, Congcong Li, Yongjie Lai, Xiaojuan Hu, Luwen Shi, Xiaodong Guan, Yang Xu. Role of Rifaximin in the Prognosis of Critically Ill Patients with Liver Cirrhosis. Antibiotics 2025; 14(3): 287 doi: 10.3390/antibiotics14030287